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Background
Mycoplasma hyopneumoniae is the primary etiologic agent
of Swine Enzootic Pneumonia (EP), one of the most
common respiratory disease that affects swine worldwide,
causing considerable economic losses. Vaccination consti-
tute one of the main practices to control EP. The produc-
tion of recombinant experimental vaccines against EP has
been considered an important approach towards the
development of an improved vaccine [1]. This study aimed
to clone a synthetic gene composed by the fusion of M.
hyopneumoniae antigens R1 (P97), P42 and NrdF to
Escherichia coli fragment B of the heat labile enterotoxin
(LTB) into the vectors pPICZB (intracellular expression)
and pPICZaB (secreted expression), in order to produce
this chimeric recombinant protein in Pichia pastoris and
to test it as a vaccine candidate. The M. hyopneumoniae
antigens were selected due to their capacity to confer par-
tial protection in pigs when evaluated individually [2-4].
These antigens were associated to LTB, a potent mucosal
and parenteral adjuvant.
Methods
The DNA fragment coding for the recombinant chimeric
protein was designed in silico [5]. The synthetic gene and
the vectors pPICZaB and pPICZB were digested with the
enzymes BamHI and EcoRI and ligated. The ligation pro-
duct was transformed into E. coli TOP10 strain, plated on
Luria - Bertani (LB) culture medium containing the anti-
biotic Zeocin™ (Invitrogen). The resulting colonies were
selected through a rapid screening method using a proto-
col with phenol - chloroform. Recombinant clones were
expanded in LB liquid medium with antibiotic, the plas-
mid was extracted and then characterized with restriction
enzymes BamHI and EcoRI.
Results and conclusions
The synthetic gene coding for the chimeric protein, com-
posed by the fusion of M. hyopneumoniae antigens R1
(P97), P42, NrdF and to LTB were efficiently cloned into
the two expression vectors in P. pastoris, pPICZB and
pPICZaB. Digestion of the recombinant clones resulted in
the release of a fragment of 1500 pb, corresponding to the
size of the insert. Future tests will be performed with these
clones in order to optimize expression of this chimeric
protein in P. pastoris.
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